Miura Partners acquires citrus flavonoid manufacturer HTBA
Spanish bioactives specialist HealthTech BioActives (HTBA) reports substantial growth over the past five years, with revenues reaching €80 million and workforce doubling to 200 employees. The Barcelona-based manufacturer of citrus flavonoids and vitamin B12 derivatives will now pursue further expansion under new majority shareholder Miura Partners.
The company operates a research, development and production facility in Beniel, Murcia, alongside its Barcelona headquarters and North American subsidiary in Cincinnati, Ohio. These facilities focus on manufacturing naturally-derived ingredients for pharmaceutical, nutraceutical, food and beverage applications.
Revenue growth
Under previous owner The Riverside Company, HTBA achieved a 66% increase in annual revenue since 2019, reaching €80 million. The company’s workforce has expanded proportionally, doubling to 200 employees across its international operations during the same period.
Technical capabilities
HTBA specialises in four key business areas: Functional Health, Pharmaceutical Active Ingredients (APIs), Taste Modulation, and Animal Nutrition. The company has developed proprietary processes for extracting and purifying citrus flavonoids and producing active forms of vitamin B12.
Commenting on the acquisition, HTBA Chief Executive Officer Alexandre Valls-Coma said: “The agreement of our new shareholder structure with Miura Partners is an important milestone for HTBA, reinforcing our position as a rising star in the health and nutrition industry.”
He added: “We remain fully focused on our mission of unlocking the power of nature through our proprietary processes and high-purity ingredients, with a genuine commitment to sustainability. Staying true to these principles has enabled us to enhance the health and well-being of both people and animals for over 40 years.”
Research focus
The company maintains ideation centres at both its Spanish headquarters and Ohio facility, enabling rapid response to changes in consumer demands across global markets. These research capabilities support HTBA’s forty-year track record in developing new processes for creating naturally-derived ingredients whilst maintaining environmental protection standards.
The acquisition by Miura Partners positions HTBA to pursue further international expansion, building on its established presence in both European and North American markets.
